Rimonabant and Cannabidiol Rewrite the Interactions between Breast Cancer Cells and Tumor Microenvironment
Open Access
- 30 August 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (17) , 13427
Abstract
The spread of breast cancer to distant sites is the major cause of death in breast cancer patients. Increasing evidence supports the role of the tumor microenvironment (TME) in breast cancers, and its pathologic assessment has become a diagnostic and therapeutic tool. In the TME, a bidirectional interplay between tumor and stromal cells occurs, both at the primary and metastatic site. Hundreds of molecules, including cytokines, chemokines, and growth factors, contribute to this fine interaction to promote tumor spreading. Here, we investigated the effects of Rimonabant and Cannabidiol, known for their antitumor activity, on reprogramming the breast TME. Both compounds directly affect the activity of several pathways involved in breast cancer progression. To mimic tumor–stroma interactions during breast-to-lung metastasis, we investigated the effect of the compounds on growth factor secretion from metastatic breast cancer cells and normal and activated lung fibroblasts. In this setting, we demonstrated the anti-metastatic potential of the two compounds, and the membrane array analyses highlighted their ability to alter the release of factors involved in the autocrine and paracrine regulation of tumor proliferation, angiogenesis, and immune reprogramming. The results enforce the antitumor potential of Rimonabant and Cannabidiol, providing a novel potential tool for breast cancer TME management.Keywords
This publication has 46 references indexed in Scilit:
- Cannabidiol: State of the art and new challenges for therapeutic applicationsPharmacology & Therapeutics, 2017
- Emerging Biological Principles of MetastasisCell, 2017
- Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti‐tumor mechanisms of Cannabidiol in breast cancerMolecular Oncology, 2015
- Signaling pathways in breast cancer: Therapeutic targeting of the microenvironmentCellular Signalling, 2014
- IGF binding proteins in cancer: mechanistic and clinical insightsNature Reviews Cancer, 2014
- Transcriptional control of cancer metastasisTrends in Cell Biology, 2013
- Molecular mechanisms mediating metastasis of hypoxic breast cancer cellsTrends in Molecular Medicine, 2012
- Interaction of endocannabinoid system and steroid Hormones in the control of colon cancer cell growthJournal of Cellular Physiology, 2011
- Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatinOncology Reports, 2009
- Hypoxia-inducible factor (HIF)-1 directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF)Carcinogenesis, 2008